Pharmafile Logo

Delphi Technique Virtual Co-creation: A Customer Story

How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints.

In this customer story, we show how our client leveraged Impetus Digital’s cutting-edge virtual tools and comprehensive digital and strategic services to organize a national virtual working group comprising 10 participants (medical oncologists and pathologists).

The client’s main objectives were to:

  1. Determine the current barriers to biomarker testing and biomarker-based treatment for non-small cell lung cancer (NSCLC), including differences in regional access and reimbursement and other pain points during the patient journey.
  2. Leverage the Delphi technique to co-create a consensus statement and algorithm on the place of biomarkers in the diagnosis, staging, treatment, and management of NSCLC using virtual touchpoints.
  3. Plan a publication based on the consensus algorithm.

To learn more about our client’s approach and the outcomes of this project, access the full customer story here.

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Search Listening as a Tool to Inform Brand Strategy & Enable Patient-Centricity

Julia Walsh, CEO of Brand Medicine International, explores the concept of “search listening” in healthcare, and how it can be used to inform brand strategy, improve patient-centricity, and fight scientific...

Top 10 Tips for Running a Successful Virtual Event

Based on 13 years of experience in virtualizing life science meetings and events

There’s No Going Back: How COVID-19 will Change Pharma Forever

Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

Leading Successful Change Through Innovative Digital Technologies

Cassie Solomon, CEO of The New Group Consulting, dives into the future of innovation, digital technologies, and systems thinking in healthcare. Among many other things, we discuss how organizations can prepare...

Alternative Approaches to Personalized Medicine in Oncology

Laura Towart, Founder & CEO of My Personal Therapeutics, discusses her company’s approach to precision medicine, the barriers patients with cancer face when trying to access personalized treatments, and how...

Reimagining Healthcare Using Mobile Health Technologies

Kim Shah, CEO of KnowYourMeds, explores digital health, AI, telemedicine, health literacy, and how to ensure a safe return to work amidst the ongoing COVID-19 pandemic. We also dive into...

Gene Editing and Precision Medicine: The Future of Healthcare?

Dr. Oscar Segurado, Chief Medical Officer at ASC Therapeutics, dives into advanced gene therapies, gene editing, and personalized medicine. We also explore the many different hats he wears as CMO, consultant,...

CRM Design and Optimization for Life Science Organizations

John Leombruno, CEO of OkRx, shares how his company is working to improve PSP strategy and operations in Canada. He also discusses the impact of COVID-19 on PSPs, digital transformation, clinical...

Enabling Patient-Focused Research Through Virtual Clinical Trials

Chad Walsh, CEO of Sciteline, dives into virtual trials, including their benefits, barriers, and impact on patient-centricity. Among other things, we will discuss data privacy concerns, the role of digital...